Log In Get Started
Press Releases May 7, 2026 05:15 PM

LeMaitre to Present at the Bank of America Healthcare Conference

LeMaitre Vascular to Present at Bank of America Healthcare Conference on May 13, 2026

By Jordan Park
Share
Twitter Reddit Facebook LinkedIn
LMAT

LeMaitre Vascular, a NASDAQ-listed company specializing in devices and implants for peripheral vascular disease, announced that its management will present at the upcoming Bank of America Healthcare Conference. The company focuses on developing and marketing solutions for vascular surgeons treating peripheral vascular disease.

LeMaitre to Present at the Bank of America Healthcare Conference
LMAT
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • LeMaitre focuses on vascular devices addressing peripheral vascular disease affecting over 200 million people globally.
  • The presentation at a major healthcare conference may provide updates on company strategy and growth prospects.
  • The company’s core market includes vascular surgeons requiring specialized disposable and implantable devices.

BURLINGTON, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT) announced today that management will present at the Bank of America Healthcare Conference on Wednesday, May 13, 2026, at 5:15 PM PT.

About LeMaitre

LeMaitre is a provider of devices, implants, and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures, and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com.


Risks

  • Market demand for peripheral vascular devices could be impacted by competition or regulatory changes.
  • Success depends on continued innovation and adoption of devices by vascular surgeons.
  • Economic or healthcare sector fluctuations could affect hospital procurement budgets and impact sales.

More from Press Releases

Space Exploration Technologies Corporation to Join the Nasdaq-100 Index® Beginning July 7, 2026 Jun 26, 2026 XMax Announces Up to Approximately US$25 million in AI API-Related Service Contracts and Expansion into GPU-as-a-Service Jun 26, 2026 Cartesian Growth Corporation IV Announces Closing of $275 Million Initial Public Offering Jun 26, 2026 dLocal added to membership of US small-cap Russell 2000® Index Jun 26, 2026 Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards and Acceptance of Plan to Regain Compliance Jun 26, 2026